Other scholars have demonstrated that METTL1 can modify the immune microenvironment by regulating the infiltration of various immune cell types, including T cells and macrophages, thereby affecting anti-tumor immune responses (72, 74). The gene discussed is METTL1; the disease is neoplasm.